Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

ARS Pharmaceuticals Inc. (SPRY : NSD)

Sector: Healthcare

Close
(03-27-2026)
$8.07
Change
-$0.49 (-5.72%)
Volume 2,382,453
Open $8.57
Day Range $7.61 - $8.64
52 Week Low $6.66
52 Week High $18.90
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $801,329,267
Shares Outstanding 99,297,307
Book Value per Share $7.02
Earnings per Share -$1.74
Period
Loading......
Loading......

Legend

ARS Pharmaceuticals Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
March 27, 2026 8.07
-$0.49 (-5.72%)
March 26, 2026 8.56
$0.66 (8.35%)
March 25, 2026 7.90
$0.36 (4.77%)
March 24, 2026 7.54
-$0.13 (-1.69%)
March 23, 2026 7.67
-$0.50 (-6.12%)
March 20, 2026 8.17
-$0.08 (-0.97%)
March 19, 2026 8.25
-$0.05 (-0.60%)
March 18, 2026 8.30
-$0.59 (-6.64%)
March 17, 2026 8.89
$0.19 (2.18%)
March 16, 2026 8.70
$0.31 (3.69%)
March 13, 2026 8.39
$0.15 (1.82%)
March 12, 2026 8.24
-$0.14 (-1.67%)
March 11, 2026 8.38
-$0.48 (-5.42%)
March 10, 2026 8.86
-$0.19 (-2.10%)
March 09, 2026 9.05
-$0.01 (-0.11%)
March 06, 2026 9.06
-$0.06 (-0.66%)
March 05, 2026 9.12
$0.08 (0.88%)
March 04, 2026 9.04
$0.17 (1.92%)
March 03, 2026 8.87
-$0.30 (-3.27%)
March 02, 2026 9.17
-$0.11 (-1.19%)
February 27, 2026 9.28
-$0.06 (-0.64%)
February 26, 2026 9.34
$0.10 (1.08%)
February 25, 2026 9.24
$0.10 (1.09%)
February 24, 2026 9.14
-$0.07 (-0.76%)
February 23, 2026 9.21
$0.21 (2.33%)
February 20, 2026 9.00
-$0.44 (-4.66%)
February 19, 2026 9.44
-$0.01 (-0.11%)
February 18, 2026 9.45
$0.07 (0.75%)
February 17, 2026 9.38
$0.53 (5.99%)
February 16, 2026 8.85
$0.00 (0.00%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports